Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.4K Buy
23,772
+9,921
+72% +$14K ﹤0.01% 1284
2026
Q1
$20.6K Buy
+13,851
New +$21.1K ﹤0.01% 1457
2025
Q4
Sell
-11,645
Closed -$16K 1541
2025
Q3
$16K Buy
+11,645
New +$15.5K ﹤0.01% 1390
2024
Q4
Sell
-61,613
Closed -$280K 2345
2024
Q3
$280K Sell
61,613
-25,190
-29% -$115K ﹤0.01% 3362
2024
Q2
$368K Buy
86,803
+46,943
+118% +$183K ﹤0.01% 2955
2024
Q1
$132K Sell
39,860
-46,904
-54% -$105K ﹤0.01% 3467
2023
Q4
$183K Buy
86,764
+1,610
+2% +$3.13K ﹤0.01% 3601
2023
Q3
$181K Buy
85,154
+32,272
+61% +$87.6K ﹤0.01% 3451
2023
Q2
$170K Buy
+52,882
New +$150K 0.01% 1065

Other funds holding GERN

GTS Securities's GERN Position: Q2 2026 in Review

GTS Securities increased its Geron (GERN) stake by 72% in Q2 2026, buying an estimated $14K and bringing the position to 23,772 shares worth $30.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

GTS Securities first reported a position in GERN in Q2 2023 and has held it in 9 quarters since. The position peaked at $368K in Q2 2024. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • GTS Securities held 23,772 shares of Geron worth $30.4K as of Q2 2026.
  • GTS Securities bought 9,921 Geron shares in Q2 2026, an estimated $14K.
  • Geron made up ﹤0.01% of GTS Securities's portfolio in Q2 2026, its #1284 holding.
  • GTS Securities first reported a position in Geron in Q2 2023 and has held it in 9 quarters since.
  • GTS Securities's Geron position peaked at $368K in Q2 2024.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.